The effects of cannabidiol via TRPV2 channel in chronic myeloid leukemia cells and its combination with imatinib
Authors:
Open Access
- 31 December 2021
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 113 (4) , 1235-1249
Abstract
Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by accumulation of immature cells in bone marrow and peripheral blood. Although successful results were obtained with tyrosine kinase inhibitors, several patients showed resistance. For this reason, the identification of new strategies and therapeutic biomarkers represents an attractive goal. The role of transient receptor potential (TRP) ion channels as possible drug targets has been elucidated in different types of cancer. Among natural compounds known to activate TRPs, cannabidiol (CBD) displays anticancer properties. By using FACS analysis, confocal microscopy, gene silencing, and cell growth assay, we demonstrated that CBD, through TRPV2, inhibits cell proliferation and cell cycle in CML cells. It promoted mitochondria dysfunction and mitophagy as shown by mitochondrial mass reduction and up‐regulation of several mitophagy markers. These effects were associated with changes in the expression of octamer‐binding transcription factor 4 and PU.1 markers regulated during cellular differentiation. Interestingly, a synergistic effect by combining CBD with the standard drug imatinib was found and imatinib‐resistant cells remain susceptible to CBD effects. Therefore, the targeting of TRPV2 by using CBD, through the activation of mitophagy and the reduction in stemness, could be a promising strategy to enhance conventional therapy and improve the prognosis of CML patients.Keywords
Funding Information
- Sapienza Università di Roma
- Università degli Studi di Camerino
This publication has 56 references indexed in Scilit:
- Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget EffectPLOS ONE, 2013
- Transient Receptor Potential Vanilloid 2 (TRPV2), a Potential Novel Biomarker in Childhood AsthmaJournal of Asthma, 2013
- Targeting Mitochondrial Dysfunction: Role for PINK1 and Parkin in Mitochondrial Quality ControlAntioxidants & Redox Signaling, 2011
- Mechanisms of mitophagyNature Reviews Molecular Cell Biology, 2010
- Non-Selective Cation Channel-Mediated Ca2+-Entry and Activation of Ca2+/Calmodulin-Dependent Kinase II Contribute to G2/M Cell Cycle Arrest and Survival of Irradiated Leukemia CellsCellular Physiology and Biochemistry, 2010
- The Atg12-Atg5 Conjugate Has a Novel E3-like Activity for Protein Lipidation in AutophagyJournal of Biological Chemistry, 2007
- Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: A Bcl-2 independent mechanismBiochimica et Biophysica Acta (BBA) - General Subjects, 2006
- LC3 conjugation system in mammalian autophagyThe International Journal of Biochemistry & Cell Biology, 2004
- Distinct thymocyte subsets express the vanilloid receptor VR1 that mediates capsaicin-induced apoptotic cell deathCell Death & Differentiation, 2004
- Calcium, ATP, and ROS: a mitochondrial love-hate triangleAmerican Journal of Physiology-Cell Physiology, 2004